Lichen International Limited
LICN
$3.12
-$0.13-4.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.20% | -21.20% | -1.90% | -1.90% | 13.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.20% | -21.20% | -1.90% | -1.90% | 13.63% |
| Cost of Revenue | 7.49% | 7.49% | -7.16% | -7.16% | 16.94% |
| Gross Profit | -39.85% | -39.85% | 1.50% | 1.50% | 11.57% |
| SG&A Expenses | 27.84% | 27.84% | 312.23% | 312.23% | 32.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.99% | 18.99% | 105.42% | 105.42% | 25.39% |
| Operating Income | -408.28% | -408.28% | -166.47% | -166.47% | -40.32% |
| Income Before Tax | -614.66% | -614.66% | -162.95% | -162.95% | -17.93% |
| Income Tax Expenses | -91.20% | -91.20% | -61.37% | -61.37% | 25.63% |
| Earnings from Continuing Operations | -1,297.13% | -1,297.13% | -198.65% | -198.65% | -43.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,319.82% | -1,319.82% | -198.93% | -198.93% | -43.48% |
| EBIT | -408.28% | -408.28% | -166.47% | -166.47% | -40.32% |
| EBITDA | -196.83% | -196.83% | -160.60% | -160.60% | 1.31% |
| EPS Basic | -833.11% | -833.11% | -164.55% | -164.55% | -57.38% |
| Normalized Basic EPS | -418.77% | -418.77% | -141.28% | -141.28% | -38.11% |
| EPS Diluted | -833.11% | -833.11% | -164.55% | -164.55% | -57.38% |
| Normalized Diluted EPS | -418.77% | -418.77% | -141.28% | -141.28% | -38.11% |
| Average Basic Shares Outstanding | 66.35% | 66.35% | 53.28% | 53.28% | 32.61% |
| Average Diluted Shares Outstanding | 66.35% | 66.35% | 53.28% | 53.28% | 32.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |